Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

28.47USD
22 Nov 2017
Change (% chg)

$-0.33 (-1.15%)
Prev Close
$28.80
Open
$28.77
Day's High
$28.81
Day's Low
$28.46
Volume
1,181,554
Avg. Vol
1,452,674
52-wk High
$29.92
52-wk Low
$19.67

Chart for

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $39,094.88
Shares Outstanding(Mil.): 1,373.20
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.56 15.46
EPS (TTM): -- -- --
ROI: -- 9.96 11.85
ROE: -- 15.22 15.83

BRIEF-Appaloosa LP cuts share stake in BofA, dissolves share stake in Wells Fargo and Activision Blizzard

* Appaloosa LP dissolves share stake in Activision Blizzard Inc - SEC filing

Nov 14 2017

Boston Scientific dips as pacemaker sales disappoint

U.S. medical device maker Boston Scientific Corp's shares fell 5 percent on Thursday after disappointing sales in its pacemaker business, even as the company reported better-than-expected revenue overall in the third quarter.

Oct 26 2017

UPDATE 2-Boston Scientific dips as pacemaker sales disappoint

Oct 26 U.S. medical device maker Boston Scientific Corp's shares fell 5 percent on Thursday after disappointing sales in its pacemaker business, even as the company reported better-than-expected revenue overall in the third quarter.

Oct 26 2017

BRIEF-Boston Scientific announces results for third quarter 2017

* Q3 earnings per share view $0.31 -- Thomson Reuters I/B/E/S

Oct 26 2017

Boston Scientific's profit rises 24 pct in 3rd quarter

Oct 26 U.S. medical device maker Boston Scientific Corp's profit rose 24 percent in the third quarter, driven by growth across all its businesses.

Oct 26 2017

11th Circuit upholds 2014 Boston Scientific mesh verdict

A federal appeals court on Thursday affirmed a trial court's $6.7 million verdict in a 2014 trial for a woman who claimed she was injured by Boston Scientific Corp's transvaginal mesh devices.

Oct 19 2017

BRIEF-Boston Scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary

* Boston scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary Source text for Eikon: Further company coverage:

Oct 04 2017

BRIEF-Boston Scientific to buy Apama Medical

* Boston Scientific announces agreement to acquire Apama Medical

Oct 02 2017

Panel refuses to revive $200 mln stent case against Boston Scientific

A federal appeals court on Friday refused to revive a $200 million patent lawsuit filed by a cardiologist against Boston Scientific Corp over coronary stents, saying a lower court judge was right to throw out a jury verdict for the doctor.

Sep 29 2017

BRIEF-Boston Scientific announces positive late-breaking clinical trial data for Heartlogic Heart Failure Diagnostic

* Boston Scientific announces positive late-breaking clinical trial data for the Heartlogic Heart Failure Diagnostic Source text for Eikon: Further company coverage:

Sep 19 2017

Competitors

Earnings vs. Estimates